The German government disclosed the six most-reported diagnoses for which medical cannabis has been prescribed and covered by statutory health insurers (GKV), with pain No. 1 followed by a muscle condition known as spasticity. The data is based on an ongoing...
Mexican lawmakers are moving closer to adopting groundbreaking legislation to establish a federally regulated cannabis industry, a move that would lay the legal foundation for a new market and make Mexico only the third country in the world to legalize commercial...
The Dutch Ministry of Health, Welfare and Sport opened a public consultation process seeking feedback on the proposed rules for a "controlled cannabis supply chain experiment," also called wietexperiment (weed experiment) by authorities. At...
The Mexican Senate’s parliamentary commissions of justice, health and legislative studies received a proposed law to establish a federally regulated adult-use marijuana industry.
The French Agency for the Safety of Medicines and Health Products (ANSM) created a scientific committee to write certain rules ahead of the launch of a two-year medical cannabis experiment. The areas of focus of the committee will be: The...
Brazilian health regulators unexpectedly postponed another vote on a groundbreaking proposal to regulate the cultivation and registration of cannabis-based medicines, delivering a further blow to efforts to open up fresh business opportunities in Latin America's...
French lawmakers appear ready to approve legislation to bankroll a two-year medical cannabis trial program for 3,000 patients, a move that would give overseas companies the opportunity to export product to what could become one of Europe's largest markets. Olivier...
The Mexican Senate's parliamentary commissions of justice, health and legislative study had a special joint meeting to provide updates on the upcoming legalization of marijuana. During the meeting, Senator Julio Ramón Menchaca Salazar, president of the Justice...
Sales of medical cannabis covered by insurance continue to increase in Germany, reaching new highs in the second quarter, according to newly released data. The steady growth in sales in the world's largest importer of medical marijuana is a good sign for the global...
Voting on resolutions to regulate the cultivation and registration of cannabis-based medicines in Brazil has been postponed, the Agência Nacional de Vigilância Sanitária - or National Sanitary Surveillance Agency (ANVISA) - announced Monday. Voting was originally...
German medical cannabis company Demecan has secured 7 million euros ($7.6 million) in financing to expand production in Europe’s largest medical market.
Brazil's Agência Nacional de Vigilância Sanitária - aka National Sanitary Surveillance Agency (ANVISA) - is expected to vote next week on two draft resolutions which could have sweeping ramifications for the medical cannabis industry. If approved, the proposals would...
